Biography/Memoir

…magic mushrooms… them…

“There isn’t really a psychedelic ‘underground’ anymore, said Jules Evans. “Everything is overground, not in the sense of legal, but in the sense of visible”. Consumer demand for psychedelic experiences remains, and players in the illegal market who were once discreet are becoming bolder. Chase, who started Psilouette in 2022 after leaving his corporate job…

READ MORE
Biography/Memoir

…the… psychedelic mushroom…

Securities Exchange Commision (SEC) filings reveal that… atai Life Sciences disposed of around 2.7 million Compass Pathways shares for gross proceeds of just over $16 million. That represents around a third of atai’s stake in Compass. Meanwhile, Colorado is reaching its second year of decriminalizing [and legalizing] mushrooms and DMT for personal use and growth… “This 70-year effort to criminalize…

READ MORE
Biography/Memoir

Psilocybin CEO arrested at airport fleeing stock fraud charges

The U.S. Department of Justice announced that the chief executive officer of psilocybin company Minerco Inc. (OTC: MINE), Julius Jenge was arrested… The former CEO was fleeing a Securities and Exchange Commission (SEC) investigation into the stock fraud allegations around the penny stock company Minerco… In 2021, the company began touting its psilocybin business and Minerco…

READ MORE
Biography/Memoir

Dr. Bronner’s gives $50,000 to psilocybin treatment center in Central Oregon

The donation shows that Dr. Bronner’s is doubling down on the Oregon experiment with psilocybin despite its troubles, as outlined in Willamette Week’s cover story… service centers are struggling to make it, costs are high, and surprising backers are showing up. Bendable Therapy… the nonprofit pairs clients with licensed guides at partner facilities for psilocybin treatment.…

READ MORE
Biography/Memoir

FDA withdraws request for White House permission to study kratom and psychedelics risks amid criticism

[Friday, August 9, 2024] “…it is time for Commissioner [Robert] Califf to exercise direct oversight and order the Agency [FDA] to reassess its biased attacks on kratom and psychedelics,” Mac Haddow, senior fellow of public policy for American Kratom Association… August 12, 2024; The Food and Drug Administration (FDA) has withdrawn a request for White…

READ MORE
Biography/Memoir

MDMA therapy didn’t get FDA approval. Now what?

The FDA declined to approve the new treatment submitted by Lykos Therapeutics, an organization that develops innovations to “transform mental healthcare,” deciding that there still isn’t enough evidence of benefit to outweigh the risks. The decision will have far-reaching ripple effects. Some psychedelic advocates will have to put celebrations they’ve been planning for decades on pause;…

READ MORE